Insider Transactions in Q1 2025 at Keros Therapeutics, Inc. (KROS)

KROS Quotes by TradingView

Insider Transaction List (Q1 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Feb 18 2025
Christopher Rovaldi Chief Operating Officer
BUY
Grant, award, or other acquisition
Direct
60,000 +50.0%
-
Feb 18 2025
Keith Regnante CHIEF FINANCIAL OFFICER
BUY
Grant, award, or other acquisition
Direct
44,000 +50.0%
-
Feb 18 2025
Yung H. Chyung Chief Medical Officer
BUY
Grant, award, or other acquisition
Direct
44,000 +50.0%
-

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS